Re:SARS-CoV-2 variant A.30 is heavily mutated and evades vac...
by nextos on Tuesday October 26, 2021 @04:52PM
(#29006105)
I think this is the logical thing to do, but now there are two new roadblocks clinical trials have to face:
* It's hard to recruit non-vaccinated participants
* There will be safety issues to address on people that have received multiple shots and / or designed against different strains
Or do a mix - first shot ancestral, second shot Delta.